뇌 모니터링 시장 규모 : 제품 유형, 모달리티, 시술, 용도, 최종 용도별 - 세계 예측(2024-2032년)

Brain monitoring market size is anticipated to observe 6.4% CAGR from 2024 to 2032, driven by the increasing prevalence of neurological disorders, such as epilepsy, Alzheimer's disease, and Parkinson's disease. As per World Federation of Neurology, around 40% of the population worldwide suffer from some kind of neurological condition and is anticipated to double by 2050.

Lately, the awareness among healthcare professionals and patients regarding the importance of early intervention in neurological conditions is significantly rising. Moreover, technological advancements in brain monitoring devices, such as electroencephalography (EEG), functional magnetic resonance imaging (fMRI), and magnetoencephalography (MEG) to enhance accuracy, sensitivity, and accessibility is driving the product adoption.

The growing aging population prone to neurological disorders and an increase in healthcare expenditure are leading to government initiatives to promote brain health. The expanding technological applications beyond clinical settings, including sports performance monitoring, cognitive enhancement, and brain-computer interface development, are offering new growth opportunities. Moreover, strategic collaborations and partnerships between healthcare organizations, academic institutions, and technology companies will enhance the market penetration.

The brain monitoring industry is divided into product type, modality, type of procedure, application, end use and region.

By application, the market size from the dementia segment is slated to witness 6.9% growth rate during 2024-2032. This is favored by the rising prevalence of dementia worldwide, particularly among the aging population. The complexity of dementia-related cognitive impairments is necessitating comprehensive and continuous monitoring to optimize patient care and management. Furthermore, the growing emphasis on R&D in dementia diagnosis and treatment is fostering innovations in brain monitoring technologies, leading to the development of more sensitive, accurate, and accessible monitoring solutions.

Based on modality, the brain monitoring market from the wearable segment will grow at 6.9% CAGR through 2032, owing to their portability, allowing continuous monitoring of brain activity outside traditional clinical settings. This accessibility enables real-time data collection and analysis for facilitating early detection of neurological disorders. Moreover, advancements in wearable technology, such as miniaturization, enhanced sensor capabilities, and wireless connectivity, helps improve device comfort, accuracy, and usability, driving adoption among both healthcare professionals and consumers.

Europe brain monitoring industry is expected to expand at 6.1% rate over 2024-2032, attributed to the aging population. The presence of robust healthcare infrastructure, leading research institutions, and supportive government initiatives in the region is fostering innovation and product adoption across clinical and research settings. Furthermore, the growing emphasis on personalized medicine and precision healthcare is driving the development of innovative brain monitoring solutions tailored to individual patient needs, further stimulating the regional market growth.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Base estimates & calculations
• 1.3 Data collection
• 1.4 Forecast parameters
• 1.5 Data validation
• 1.6 Data sources
  • 1.6.1 Primary
  • 1.6.2 Secondary
    • 1.6.2.1 Paid sources
    • 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

• 2.1 Industry 360-degree synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing incidence of neurological disorders
    • 3.2.1.2 Advancements in technology
    • 3.2.1.3 Growing awareness and focus on brain health
    • 3.2.1.4 Rise in research and development activities
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 High cost of brain monitoring devices
    • 3.2.2.2 Privacy and ethical concerns
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technological landscape
• 3.6 Porter's analysis
  • 3.6.1 Supplier power
  • 3.6.2 Buyer power
  • 3.6.3 Threat of new entrants
  • 3.6.4 Threat of substitutes
  • 3.6.5 Industry rivalry
• 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2018 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Devices
  • 5.2.1 Magnetoencephalograph devices
  • 5.2.2 Electroencephalograph
  • 5.2.3 Cerebral oximeters
  • 5.2.4 Functional magnetic resonance imaging (fMRI)
  • 5.2.5 Intracranial pressure monitoring devices
  • 5.2.6 Computerized tomography scanners (CT)
  • 5.2.7 Positron emission tomography (PET)
  • 5.2.8 Sleep monitoring devices
  • 5.2.9 Electromyography devices (EMG)
  • 5.2.10 Transcranial doppler devices (TCD)
  • 5.2.11 Other devices
• 5.3 Accessories
  • 5.3.1 Electrodes
  • 5.3.2 Sensors
  • 5.3.3 Caps
  • 5.3.4 Cables
  • 5.3.5 Paste or gel
  • 5.3.6 Other accessories

Chapter 6 Market Estimates and Forecast, By Modality, 2018 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Fixed
• 6.3 Portable
• 6.4 Wearable

Chapter 7 Market Estimates and Forecast, By Type of Procedure, 2018 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Invasive
• 7.3 Non-invasive

Chapter 8 Market Estimates and Forecast, By Application, 2018 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 Parkinson's disease
• 8.3 Traumatic brain injury
• 8.4 Epilepsy
• 8.5 Dementia
• 8.6 Sleep disorders
• 8.7 Stroke
• 8.8 Migraine
• 8.9 Other applications

Chapter 9 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)

• 9.1 Key trends
• 9.2 Hospitals
• 9.3 Neurology centers
• 9.4 Diagnostic centers
• 9.5 Other end-users

Chapter 10 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

• 10.1 Key trends
• 10.2 North America
  • 10.2.1 U.S.
  • 10.2.2 Canada
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 France
  • 10.3.4 Italy
  • 10.3.5 Spain
  • 10.3.6 Rest of Europe
• 10.4 Asia Pacific
  • 10.4.1 China
  • 10.4.2 Japan
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 South Korea
  • 10.4.6 Rest of Asia Pacific
• 10.5 Latin America
  • 10.5.1 Brazil
  • 10.5.2 Mexico
  • 10.5.3 Argentina
  • 10.5.4 Rest of Latin America
• 10.6 Middle East and Africa
  • 10.6.1 South Africa
  • 10.6.2 Saudi Arabia
  • 10.6.3 UAE
  • 10.6.4 Rest of Middle East and Africa

Chapter 11 Company Profiles

• 11.1 BrainScope Company, Inc.
• 11.2 Cadwell Industries, Inc.
• 11.3 Compumedics Limited
• 11.4 Edwards Lifesciences
• 11.5 Elekta AB
• 11.6 GE Healthcare
• 11.7 Koninklijke Philips N.V.
• 11.8 Medtronic plc
• 11.9 Natus Medical Incorporated
• 11.10 Siemens Healthineers AG